Efficacy Safety and Tolerability of Dispersible and Immediate Release AbacavirDolutegravirLamivudine Tablets in Children with HIV IMPAACT 2019 Week 48 Results

Simple item page
dc.article.end-page784en
dc.article.start-page777en
dc.citation.doi10.1097/INF.0000000000004859en
dc.contributor.authorH Rabieen
dc.contributor.authorDE Yinen
dc.contributor.authorS Warden
dc.contributor.authorY Ranien
dc.contributor.authorHaseena Cassimen
dc.contributor.authorFaeezah Patelen
dc.contributor.authorE et alen
dc.date.accessioned2026-03-26T14:16:34Z
dc.departmentWITS REPRODUCTIVE HEALTH AND HIV INSTITUTEen
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0891-3668en
dc.identifier.urihttps://hdl.handle.net/10539/48739
dc.journal.titleEfficacy Safety and Tolerability of Dispersible and Immediate Release AbacavirDolutegravirLamivudine Tablets in Children with HIV IMPAACT 2019 Week 48 Resultsen
dc.journal.volume44en
dc.publisherLIPPINCOTT WILLIAMS & WILKINSen
dc.titleEfficacy Safety and Tolerability of Dispersible and Immediate Release AbacavirDolutegravirLamivudine Tablets in Children with HIV IMPAACT 2019 Week 48 Resultsen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
815.62 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)